A major hospital advocacy group recently warned that October 2024 agency guidance on Medicare drug price negotiations may allow drugmakers [...] …
Category: Providers
Federal lawmakers late last week approved a pared-down, must-pass federal spending bill, which cut back on health center funding and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Biogen will soon extend its contract pharmacy restrictions to non-hospital covered entities, while Novartis will require hospitals to submit claims [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Michigan’s legislative session concluded in disarray last week after the House abruptly adjourned without enough members present to vote on [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge’s recent ruling against West Virginia’s 340B contract pharmacy law advances the drug industry’s push to bring the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B Report [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In the first major legal setback for states pursuing contract pharmacy protections, a federal district judge ruled yesterday that West Virginia officials cannot enforce the state’s contract pharmacy access law while three drug industry legal challenges play out.
U.S. District
…
Emerging regulatory conflicts between the Inflation Reduction Act (IRA) and the 340B program may soon force policymakers to enact major [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AbbVie’s latest move to extend certain 340B contract pharmacy restrictions to federal grantees also appears to target hospitals’ use of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
French pharmaceutical giant Sanofi late yesterday announced it would pause the implementation of its contested 340B rebate plan and become [...] …